Delek US Holdings, Inc. (NYSE:DK) COO Sells $280000.00 in Stock

Lloyd Doyle
November 15, 2017

Piper Jaffray maintained Delek US Holdings, Inc. Insiders own 1.61% of the company's stock.

About 454,887 shares traded or 68.14% up from the average. The stock of Delek US Holdings, Inc. It has outperformed by 73.26% the S&P500.

The stock of Foundation Medicine Inc (NASDAQ:FMI) is a huge mover today! (NYSE:DK) has risen 89.96% since November 13, 2016 and is uptrending. The monthly stock performance comes in at 21.15%. We have $43.68 PT which if reached, will make NASDAQ:FMI worth $119.00M less.

Orexigen Therapeutics, a biopharmaceutical company. The company has market cap of $7.03 billion. It is engaged in the business of delivering molecular information about cancer to its customers. (NYSE:HBI) to report earnings on February, 1. Analysts forecast earnings per share of $0.24, up exactly $0.68 or 154.55 % from 2014's $-0.44 EPS. After posting $0.81 EPS for the previous quarter, Delek US Holdings, Inc.'s analysts now forecast -70.37 % negative EPS growth. (NYSE:DK). Bnp Paribas Arbitrage stated it has 15,068 shares or 0% of all its holdings. Tower Rech Capital (Trc) has invested 0.01% in Foundation Medicine Inc (NASDAQ:FMI). Vanguard Group accumulated 6.96 million shares or 0.01% of the stock. Hodges Capital Management Inc. owns 1.04 million shares or 1.2% of their USA portfolio. 10,590 are owned by Aqr Capital Mngmt Lc. Moreover, Jhl Capital Group Llc has 1.2% invested in the company for 310,000 shares. Royal National Bank & Trust Of Canada holds 0% or 176,168 shares. Magnetar Ltd has 13,316 shares for 0.01% of their portfolio. Out of 3 Wall Street analysts rating Commercial Metals, 1 give it "Buy", 0 "Sell" rating, while 2 recommend "Hold". Therefore 22% are positive. (NYSE:DK) rating on Thursday, June 15. The firm has "Buy" rating by Cowen & Co given on Friday, July 7. The rating was maintained by UBS on Friday, February 3 with "Buy". JP Morgan has "Neutral" rating and $12 target. The stock of Foundation Medicine Inc (NASDAQ:FMI) has "Market Perform" rating given on Wednesday, September 16 by Wells Fargo. The firm has "Market Perform" rating by JMP Securities given on Wednesday, March 16.

Since May 22, 2017, it had 0 insider buys, and 10 selling transactions for $6.18 million activity. Another trade for 20,000 shares valued at $520,000 was sold by Ginzburg Assi.

Cowen and Company reissued their buy rating on shares of Delek US Holdings, Inc. (NYSE:DK) rating on Friday, July 24. It indicates oversold and overbought price levels for a stock.

In other news, Director Charles H. Leonard sold 2,500 shares of the stock in a transaction dated Tuesday, August 15th. Another trade for 741 shares valued at $18,844 was sold by Miller Anthony L. 713 shares were sold by Holmes Donald Norman, worth $19,750. Raymond James Financial, Inc. upgraded Delek US Holdings from an "outperform" rating to a "strong-buy" rating and upped their target price for the company from $32.00 to $35.00 in a research report on Monday. Delek US Holdings had 56 analyst reports since July 24, 2015 according to SRatingsIntel. Barclays Capital downgraded Delek US Holdings, Inc. (NYSE:DK). Voya Investment Mngmt Limited Liability Com has 0% invested in Delek US Holdings, Inc. (NYSE:DK). Virginia Retirement System Et Al holds 0% or 9,145 shares. The company was maintained on Wednesday, October 18 by RBC Capital Markets. JP Morgan downgraded Delek US Holdings, Inc. On Thursday, May 25 Page Mark T. sold $20,959 worth of Delek US Holdings, Inc. (NYSE:DK) earned "Neutral" rating by Bank of America on Monday, October 19. The rating was maintained by Barclays Capital on Friday, August 5 with "Equal-Weight". The company was maintained on Thursday, August 3 by RBC Capital Markets.

Investors sentiment decreased to 1.01 in Q2 2017. Its down 0.26, from 1.27 in 2017Q1. It fall, as 40 investors sold Delek US Holdings, Inc. shares while 34 reduced holdings. 37 funds opened positions while 38 raised stakes. Finally, Bank of New York Mellon Corp grew its holdings in shares of Delek US Holdings by 4.6% during the 2nd quarter. Public Employees Retirement Association Of Colorado invested 0% in Delek US Holdings, Inc. Delek US Holdings has a twelve month low of $17.31 and a twelve month high of $29.16. (NYSE:DK) for 27,817 shares. The company now has a consensus rating of Hold and a consensus price target of $29.50. As per Monday, December 12, the company rating was upgraded by CL King. Water Island Ltd Liability Corporation, New York-based fund reported 242,993 shares. (NYSE:DK) or 825 shares.

Wall Street await Delek US Holdings, Inc. (NYSE:DK) or 2.42M shares. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.19%.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Iphone Fresh

Discuss This Article